Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...

全面介绍

Saved in:
书目详细资料
Main Authors: Qi-An Chen (Author), Wei-Hao Lin (Author), Xiao-Xiang Zhou (Author), Zheng Cao (Author), Xiao-Li Feng (Author), Yi-Bo Gao (Author), Jie He (Author)
格式: 图书
出版: Elsevier, 2024-02-01T00:00:00Z.
主题:
在线阅读:Connect to this object online.
标签: 添加标签
没有标签, 成为第一个标记此记录!

因特网

Connect to this object online.

3rd Floor Main Library

持有资料详情 3rd Floor Main Library
索引号: A1234.567
复印件 1 可用